Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples